Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2011 Mar 1;17(10):1460–1471. doi: 10.1016/j.bbmt.2011.02.001

Table 3.

Number, type and incidence of serious viral infections by time period: the peak incidence was during 31-60 days post-transplant, CMV was the most common infection, and lethal infections were limited to the first 120 days post-transplant.

Time
Period
(N Patients
at Risk)
N
Infections//
N (%)
Patients with
One or More
Infection
Type Severity

Admit-30
(N=72)
19 infections//
15/72 (21%)
of patients.
4 CMV: 2 viremia, 1 pneumonia*,
 1 enteritis/ colitis*.
2 severe, 1 life-threatening,
 1 lethal**.
10 HHV6: 9 viremia, 1 encephalitis. 9 severe; 1 lethal**.
4 BK hemorrhagic cystitis. 4 severe.
1 Adenovirus UTI. 1 severe.
31-60
(N=67)
21 infections//
20/67 (30%)
of patients.
15 CMV: 12 viremia, 1 pneumonia*,
1 enteritis/ colitis*, 1 URI.
13 severe, 1 life-threatening,
 1 lethal**.
1 HHV6 viremia. 1 severe.
4 BK hemorrhagic cystitis. 4 severe.
1 Adenovirus enteritis/ colitis*. 1 lethal**.
61-120
(N=65)
10 infections//
10/65 (15%)
of patients.
4 CMV viremia. 4 severe.
1 Adenovirus enteritis/ colitis*. 1 lethal**.
1 RSV URI. 1 severe.
1 Influenza URI. 1 severe.
2 Herpes Zoster (single dermatome). 2 severe.
1 HSV mucositis. 1 severe.
121-180
(N=47)
6 infections//
6/47 (13%)
of patients.
3 CMV viremia. 3 severe.
1 EBV viremia. 1 severe.
1 RSV pneumonia. 1 life-threatening.
1 Influenza URI. 1 severe.
180-1 year
(N=36)
6 infections//
6/36 (17%)
of patients.
2 CMV viremia. 2 severe.
4 EBV: 3 viremia, 1 NHL. 4 severe.
*

Patients with pneumonia or gut disease also had viremia.

**

Five patients had lethal viral infections: 1 CMV pneumonia and 1 HHV6 encephalitis directly contributed to death whereas in 3 patients viral infections contributed to death (1 patient with early onset CMV infection who subsequently had graft failure and 2 with adenovirus whose primary cause of death was GVHD).

Abbreviations: CMV, cytomegalovirus; HHV6, human herpes virus 6; UTI, urinary tract infection; URI, upper respiratory tract infection; RSV, respiratory syncytial virus; HSV, herpes simplex virus; EBV, Epstein-Barr virus; NHL, Non-Hodgkin lymphoma.